Therapeutic Asset Ratings
534 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pidnarulex
Cancer
Senhwa Biosciences, Inc.
P1
C
(36)
Plb-002
Cancer
Primelink BioTherapeitics(ShenZhen) Limited
P1
C
(36)
Plx-61639
Cancer
Plexium, Inc.
P1
C
(36)
pm54
Cancer
PharmaMar
P1
C
(36)
Precious-01
Cancer
Radboud University Medical Center
P1
C
(36)
prt7732
Cancer
Prelude Therapeutics
P1
C
(36)
qlf3108
Cancer
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
qls1103
Cancer
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
qls12004
Cancer
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
qls31904
Cancer
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
qtx3046
Cancer
Quanta Therapeutics
P1
C
(36)
ret01 act
Cancer
Aeonvital Biomedicine
P1
C
(36)
Rgt-264 Phosphate Tablets
Cancer
Regor Pharmaceuticals Inc.
P1
C
(36)
Rgt-419B
Cancer
Regor Pharmaceuticals Inc.
P1
C
(36)
Rimo-401
Cancer
Coordination Pharmaceuticals, Inc.
P1
C
(36)
rp-1664
Cancer
Repare Therapeutics
P1
C
(36)
rp3
Cancer
Replimune, Inc.
P1
C
(36)
RP-3467
Cancer
Repare Therapeutics
P1
C
(36)
rt001
Advanced Solid Tumor
The First Affiliated Hospital of Bengbu Medical University
P1
C
(36)
S095012
Cancer
Institut de Recherches Internationales Servier
P1
C
(36)
sc-101
Cancer
Tianjin ConjuStar Biologics Co., Ltd.
P1
C
(36)
Sgr-3515
Cancer
Schrödinger, Inc.
P1
C
(36)
Shr-1049
Cancer
Jiangsu HengRui Medicine Co., Ltd.
P1
C
(36)
Shr-4602 For
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P1
C
(36)
Shr-4712
Cancer
Guangdong Hengrui Pharmaceutical Co., Ltd
P1
C
(36)
Showing 426 to 450 of 534 assets
Previous
Page 18 of 22
Next